About Agenda Exhibits  Registration 

Cancer Diagnosis

Can Technology Advance Early Diagnosis?


It is generally recognised that early diagnosis significantly improves cancer survival rates; advances in technology are leading to achieving that desirable outcome.  The Cancer Diagnostic Technology Summit provides a platform for leading developers to showcase the current and future directions of technology in cancer diagnosis.  The Conference will explore advances in a range of diagnostic methodologies, and concerns that very early diagnosis may lead to treatment of biologically insignificant cancers.

Key Technologies



Blood biopsy

Biomarkers in breath, saliva and urine

Cell separation and DNA sequencing

AI in imaging and data mining

Call for Papers



Contact Sensor100 if you would like to present at CDT21:

Companies with cancer diagnostic technology at any stage of development

Early stage companies developing innovative diagnostic technology

Academic and clinical research teams

Oral and Poster Abstracts - please specify which.  Posters will have an opportuinity to give a short presentation   

Send a brief abstract to cdt21@sensor100.com

Follow the Template Guidelines for inclusion in the Conference Book of Abstracts

Abstract deadline: 12 March

Supported by



Imperial College Network of Excellence in Cancer Technology

Sensor100 

Organising Committee

 Prof. H Thomas Aretz MD, Harvard Medical School and Partners International

Dr. Michael Brand, Sensor100

Dr. Kalypso Charalambous, Institute of Biomedical Engineering, Imperial College London

Dr. Sylvain Ladame, Department of Bioengineering, Imperial College London